Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Acting Commissioner Sharfstein Starts Agency Overhaul

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Sharfstein takes pre-emptive action on pistachio safety, asks agency staffers to submit short-term ideas for improving FDA.

You may also be interested in...



More Salmonella Problems Point To Holes In Food GMPs

The recall of more than 2 million pounds of pistachios due to contamination could spike complaints about holes in food manufacturing regulations

FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down

FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills

FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down

FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

Are Regulators Ready For The Robot Era? ChatGPT Weighs In On EU Regulation

Pink Sheet Podcast: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings

Recent And Upcoming FDA Advisory Committee Meetings

EU CHMP Opinions and MAA Updates

See All
UsernamePublicRestriction

Register

PS069256

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By